EP3946427A1 — Medication delivery systems and methods
Assigned to Amphastar Pharmaceuticals Inc · Expires 2022-02-09 · 4y expired
What this patent protects
The present disclosure relates to a medication delivery system (10) including a medication administration device (12), a medication within the medication administration device (12), a container (14) defining a cavity (32) receiving the medication administration device (12), and a…
USPTO Abstract
The present disclosure relates to a medication delivery system (10) including a medication administration device (12), a medication within the medication administration device (12), a container (14) defining a cavity (32) receiving the medication administration device (12), and a cap (16) attached to the container (14) and sealing the medication administration device (12) within the cavity (32). The medication administration device (12) includes an actuator (26) extending from a body (18) and operable to expel the medication by depressing the actuator (26) into the body (18). The cap (16) includes hold down members (44) positioned to bear against the body (18) of the medication administration device (12) to prevent movement of the medication administration device (12) toward the cap (16) beyond a predetermined distance. The medication administration device (12) is thereby prevented, inter alia, from prematurely discharging the medication during storage and transport.
Drugs covered by this patent
- Glucagen (GLUCAGON) · Xeris
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.